Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation
3DATGvsCT
Randomized Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation
1 other identifier
observational
37
1 country
2
Brief Summary
The purpose of this study is to compare rotational angiography (3DATG technology)intra-procedure (during the ablation procedure) with CT (x-ray) pre-procedure (before the ablation procedure) fusion to create an anatomical picture of a heart to help adequately guide an ablation procedure for patients with arrhythmias.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2011
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 3, 2012
CompletedFirst Posted
Study publicly available on registry
February 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedNovember 25, 2014
March 1, 2012
2 years
January 3, 2012
November 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of procedural success for an ablation procedure using 3DATG fusion
Case report forms were created to capture intraprocedure data (i.e.noticeable map drift) of the maps created and used to create ablation lesions. Procedure user's overall clinical evaluation (i.e.feedback) and experience (i.e. radiation time, number of mapping points collected per map, mapping time) will also be collected and analyzed. And patients will be followed as routine for overall disease evaluation (i.e. ECG and patient reported symptoms) within 6 months from the procedure.
within 6 months
Secondary Outcomes (1)
Overall radiation exposure to the patient
Pre-procedure (for CT cohort) to end of procedure
Study Arms (2)
intra-procedure 3DATG
Patients who will undergo intra-procedure 3DATG rotational angiography to guide their ablation procedure
pre-procedure CT
Patients who will undergo pre-procedure CT scan to guide their ablation procedure
Eligibility Criteria
All patients undergoing a clinically indicated left-sided ablation procedure for atrial fibrillation who therefore satisfy conventional criteria for catheter ablation.
You may qualify if:
- All patients undergoing a clinically indicated left-sided ablation procedure for atrial fibrillation
You may not qualify if:
- Patients not willing or able to provide consent to participate or already involved in another clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Holy Cross Hospital
Fort Lauderdale, Florida, 33308, United States
St. Elizabeth's Medical Center
Brighton, Massachusetts, 02135, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael V Orlov, MD, PhD
St. Elizabeth's Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2012
First Posted
February 23, 2012
Study Start
August 1, 2011
Primary Completion
August 1, 2013
Study Completion
November 1, 2014
Last Updated
November 25, 2014
Record last verified: 2012-03